I
Ilker Tasci
Researcher at University of Health Sciences Antigua
Publications - 207
Citations - 2035
Ilker Tasci is an academic researcher from University of Health Sciences Antigua. The author has contributed to research in topics: Medicine & Sarcopenia. The author has an hindex of 22, co-authored 190 publications receiving 1791 citations. Previous affiliations of Ilker Tasci include Turkish Ministry of Health & Yahoo!.
Papers
More filters
Journal ArticleDOI
The effect of combination therapy of hyperbaric oxygen, meropenem, and selective nitric oxide synthase inhibitor in experimental acute pancreatitis.
Ahmet Turan Isik,Mehmet Refik Mas,Bilgin Comert,Mehmet Yasar,Ahmet Korkmaz,Cemal Akay,Salih Deveci,Ilker Tasci,Nuket Mas,Yüksel Ateş,Ismail Hakki Kocar +10 more
TL;DR: It is suggested that adding the HBO therapy as an adjunctive to the treatment protocol of acute necrotizing pancreatitis may yield improvement in the morbidity and mortality of the disease.
Journal ArticleDOI
Brain derived neurotrophic factor (BDNF) in cardiometabolic physiology and diseases.
TL;DR: The most recent advances in the functions of brain derived nerve growth factor (BDNF), a major type of neurotrophins, are described, focusing primarily on cardiovascular and metabolic diseases.
Journal ArticleDOI
Frailty status and increased risk for falls: The role of anticholinergic burden
Mehmet Ilkin Naharci,Ilker Tasci +1 more
TL;DR: It was showed that the use of any drugs with possible or definite anticholinergic properties was associated with an increased risk of falls in frail older adults, emphasizing the importance of medication management with respect to fall prevention in these patients.
Journal ArticleDOI
Doppler ultrasonography in lower extremity peripheral arterial disease.
Samet Verim,Ilker Tasci +1 more
TL;DR: In this article, supporting evidence for the use of Doppler ultrasonography (US) in the diagnosis of lower extremity peripheral arterial disease (PAD) is discussed.
Journal ArticleDOI
Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome.
Halil Genc,Teoman Dogru,Serkan Tapan,Ilker Tasci,Ergun Bozoglu,Mahmut Gok,Fatih Aslan,Gurkan Celebi,Gokhan Erdem,Ferit Avcu,Ali Uğur Ural,Alper Sonmez +11 more
TL;DR: Blood levels of soluble CD40 ligand, soluble P-selectin and von Willebrand Factor in subjects with prediabetes, along with the effects of the metabolic syndrome, imply that MetS may contribute, at least in part, to the mechanism of platelet activation and endothelial dysfunction in people withprediabetes.